NCT06335797

Optimization of Postoperative Bowel Habits

Name: Clinical Trial NCT06335797
Creator: Wake Forest University Health Sciences
Keywords: Constipation, Senna Tab, dietary supplement, clinical trial, United States of America

Optimization of Postoperative Bowel Habits Following Pelvic Reconstructive Surgery: a Randomized Controlled Trial

Wake Forest University Health Sciences·ClinicalTrials.gov·dietary supplementNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Constipation
Drug/Device/Intervention: Senna Tab
Study type: Interventional
Intervention type: dietary supplement

Sponsor & location

Primary sponsor: Wake Forest University Health Sciences
Location: Winston-Salem, United States of America

Timeline & enrollment

Phase: N/A
Start date: May 01, 2024
End date: Dec 01, 2025
Enrollment: 88 participants

Primary outcome

Time in hours to first bowel movement comparison between the two arms

Summary

Project is a trial, in which women undergoing vaginal surgery for pelvic organ prolapse will be randomized 1:1 to a postoperative bowel regimen of either oral senna or rectal bisacodyl suppository.

ICD-10 classifications

ConstipationIrritable bowel syndrome with predominant constipation [IBS-C]Other laxativesPoisoning: Other laxativesOther functional intestinal disorders

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06335797
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06335797 through Pure Global AI's free database. This phase not specified trial is sponsored by Wake Forest University Health Sciences and is currently Not yet recruiting. The study focuses on Constipation. Target enrollment is 88 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.